WealthTrust Axiom’s MediciNova MNOV Stock Holding History

WealthTrust Axiom’s Portfolio MNOV Stock Details MNOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-12,500	Closed	-$26.3K	–	262
2024 Q4	$26.3K	Hold	12,500	–	–	0.01%	252
2024 Q3	$26.3K	Hold	12,500	–	–	0.01%	261
2024 Q2	$18K	Hold	12,500	–	–	0.01%	253
2024 Q1	$18.1K	Hold	12,500	–	–	0.01%	260
2023 Q4	$18.8K	Hold	12,500	–	–	0.01%	251
2023 Q3	$26.1K	Hold	12,500	–	–	0.01%	236
2023 Q2	$28.8K	Hold	12,500	–	–	0.01%	249
2023 Q1	$27K	Hold	12,500	–	–	0.01%	244
2022 Q4	$25.6K	Hold	12,500	–	–	0.01%	239
2022 Q3	$27K	Hold	12,500	–	–	0.01%	236
2022 Q2	$31K	Hold	12,500	–	–	0.01%	238
2022 Q1	$33K	Hold	12,500	–	–	0.01%	256
2021 Q4	$33K	Hold	12,500	–	–	0.01%	257
2021 Q3	$47K	Hold	12,500	–	–	0.02%	247
2021 Q2	$53K	Buy	+12,500	New	+$53.8K	0.02%	260

Other funds holding MNOV

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

WealthTrust Axiom's MNOV Position: Q1 2025 in Review

WealthTrust Axiom sold out of MediciNova (MNOV) in Q1 2025, closing a stake of 12,500 shares — an estimated $26.3K sold.

WealthTrust Axiom first reported a position in MNOV in Q2 2021 and held it in 15 quarters. The position peaked at $53K in Q2 2021. 28 funds tracked by Wall St. Rank hold MNOV as of Q1 2025.

WealthTrust Axiom reported no remaining MediciNova position as of Q1 2025 after selling out during the quarter.
WealthTrust Axiom sold 12,500 MediciNova shares in Q1 2025, an estimated $26.3K.
WealthTrust Axiom first reported a position in MediciNova in Q2 2021 and held it in 15 quarters.
WealthTrust Axiom's MediciNova position peaked at $53K in Q2 2021.
28 funds tracked by Wall St. Rank held MediciNova as of Q1 2025.

Based on WealthTrust Axiom's 13F filing for Q1 2025, filed 14 May 2025.